The invention concerns novel 5-sulphanyl-4H-1,2,4-triaz-
ole derivatives of formula (1), wherein: R.sub.1, R.sub.2 and R.sub.3
represent variable groups and the methods for preparing them by
liquid-phase parallel synthesis processes. Said product exhibit good
affinity for certain sub-types of somatostatin receptors; they are
particularly useful for treating pathological conditions or diseases
wherein one (or more) somatostatin receptors is (are) involved. The
invention also concerns pharmaceutical compositions containing said
products and their use for preparing a medicine. 1
